StockWatch
·
Biotechnology: Pharmaceutical Preparations
BuybackAug 12, 2026, 04:48 PM

Lakefront Repurchases 103,970 Shares for €2.41M

AI Summary

Lakefront Biotherapeutics announced the repurchase of 103,970 of its own shares between August 3 and August 7, 2026, as part of a program initiated on June 9, 2026. The total cost for these repurchases amounted to €2,409,901.40, with an average price of €23.18 per share. Following these transactions, the company holds 808,186 of its own ordinary shares as of August 7, 2026.

Key Highlights

  • Repurchased 103,970 shares between August 3 and August 7, 2026.
  • Total cost of the buyback was €2,409,901.40.
  • Average price paid per share was €23.18.
  • Lakefront Biotherapeutics now holds 808,186 of its own ordinary shares.